Target intelligence / Profile preview

Off-target messenger RNAs with partial complementarity to X-linked inhibitor of apoptosis protein small interfering RNA guide strand

Molecular classification
Messenger RNA
01

Overview

Off-target messenger RNAs of X-linked inhibitor of apoptosis protein (XIAP) small interfering RNA (siRNA) refer to a heterogeneous group of transcripts that are unintentionally regulated by siRNAs designed to silence XIAP. This process is mediated by the RNA-induced silencing complex (RISC), where the siRNA guide strand recognizes non-target transcripts through partial sequence homology, particularly within the 6-7 nucleotide 'seed' region (Jackson et al., 2003, Nature Biotechnology). These interactions typically occur in the 3' untranslated regions (UTRs) of the off-target mRNAs and result in their degradation or translational inhibition, a mechanism analogous to endogenous microRNA (miRNA) function (Birmingham et al., 2006, Nature Methods). Because XIAP is a key regulator of apoptosis, siXIAP is frequently used in oncology research; however, the silencing of unintended off-target mRNAs can induce 'off-target toxicity' or phenotypic changes that complicate the interpretation of experimental data (Fedorov et al., 2006, RNA). These transcripts are not therapeutic targets but are instead considered a major technical and safety challenge in the development of RNAi-based therapeutics. To mitigate these effects, developers utilize chemical modifications and advanced sequence design to enhance the specificity of the siRNA for the intended XIAP mRNA.

Other names
siRNA off-targetsSeed-matched off-target transcriptsmiRNA-like off-target effectssiXIAP off-target transcripts
02

Mechanism of action

Unintended silencing of transcripts through RISC-mediated degradation or translational inhibition driven by partial sequence homology, primarily in the 3' UTR.

03

Biological functions

RNA interferencePost-transcriptional gene regulation
04

Disease associations

Off-target toxicity
05

Safety considerations

Non-specific toxicityConfounding experimental dataUnintended phenotypic changes
06

Interacting drugs

siXIAP
07

Biomarkers

Differential gene expressionRNA-seq analysis

Beyond the preview

Go deeper on Off-target messenger RNAs with partial complementarity to X-linked inhibitor of apoptosis protein small interfering RNA guide strand.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Off-target messenger RNAs with partial complementarity to X-linked inhibitor of apoptosis protein small interfering RNA guide strand.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call